GlaxoSmithKline, Vir Biotechnology begin late-stage testing of experimental Covid-19 therapy
August 31, 2020 at 11:13 AM EDT
The new drug candidate is being developed for the early treatment of Covid-19 in patients who are at high risk of hospitalization.
